A. F. Catoi, “Increased Chemerin and Decreased Omentin-1 Levels in Morbidly Obese Patients are Correlated with Insulin Resistance, Oxidative Stress and Chronic Inflammation”, Med Pharm Rep, vol. 87, no. 1, pp. 19–26, Mar. 2014.